CL2013002989A1 - Composicion para ser transferida a un ovocito que es preparado para fertilizacion in vitro o inseminacion artificial. - Google Patents

Composicion para ser transferida a un ovocito que es preparado para fertilizacion in vitro o inseminacion artificial.

Info

Publication number
CL2013002989A1
CL2013002989A1 CL2013002989A CL2013002989A CL2013002989A1 CL 2013002989 A1 CL2013002989 A1 CL 2013002989A1 CL 2013002989 A CL2013002989 A CL 2013002989A CL 2013002989 A CL2013002989 A CL 2013002989A CL 2013002989 A1 CL2013002989 A1 CL 2013002989A1
Authority
CL
Chile
Prior art keywords
composition
oocyte
osc
mitochondria
transferred
Prior art date
Application number
CL2013002989A
Other languages
English (en)
Inventor
Dori C Woods
Jonathan Lee Tilly
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47010014&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013002989(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of CL2013002989A1 publication Critical patent/CL2013002989A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

El invento se relaciona con una composición para ser transferida en un ovocito que es preparado para fertilización in vitro (IVF) o inseminación artificial porque comprende i) mitocondrias de células madres oogoniales (OSC) o ii) mitocondrias aisladas de una progenie de una OSC, donde la OSC es autóloga para el ovocito, no es una célula madre embrionaria, es mitóticamente competente, expresa Vasa, Oct-4, Dazl, Stella y opcionalmente, un antígeno embrionario etapa especifico. También se relaciona con un ovocito que comprende la composición de mitocondrias de células madres oogoniales. Y por último, el invento describe un método para preparar un ovocito que incluye la etapa de transferir la composición de mitocondrias de OSC en el ovocito
CL2013002989A 2011-04-14 2013-10-14 Composicion para ser transferida a un ovocito que es preparado para fertilizacion in vitro o inseminacion artificial. CL2013002989A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161475561P 2011-04-14 2011-04-14
US201261600505P 2012-02-17 2012-02-17

Publications (1)

Publication Number Publication Date
CL2013002989A1 true CL2013002989A1 (es) 2014-05-02

Family

ID=47010014

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013002989A CL2013002989A1 (es) 2011-04-14 2013-10-14 Composicion para ser transferida a un ovocito que es preparado para fertilizacion in vitro o inseminacion artificial.

Country Status (24)

Country Link
US (5) US8647869B2 (es)
EP (3) EP3498826A1 (es)
JP (3) JP5793237B2 (es)
CN (2) CN103562378B (es)
AP (1) AP2013007229A0 (es)
AU (1) AU2012242591B2 (es)
BR (1) BR112013026501A2 (es)
CA (2) CA2832336C (es)
CL (1) CL2013002989A1 (es)
CO (1) CO6862102A2 (es)
CR (1) CR20130592A (es)
DO (1) DOP2013000240A (es)
EA (1) EA201391523A1 (es)
GT (1) GT201300248A (es)
HK (1) HK1202890A1 (es)
IL (3) IL228829A (es)
MA (1) MA35105B1 (es)
MX (1) MX2013011990A (es)
NI (1) NI201300108A (es)
NZ (1) NZ706806A (es)
PE (1) PE20141517A1 (es)
SG (2) SG10201406171QA (es)
WO (1) WO2012142500A2 (es)
ZA (2) ZA201308494B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1765983A4 (en) 2004-05-17 2008-10-22 Gen Hospital Corp METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STEM CELLS FROM GERMINAL STEM CELLS DERIVED FROM SPINAL CORD
US7955846B2 (en) 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
CN103562378B (zh) 2011-04-14 2016-09-07 通用医疗公司 用于自体种系线粒体能量转移的组合物和方法
EP3495470A1 (en) 2011-06-29 2019-06-12 The General Hospital Corporation In vivo methods for enhancing bioenergetic status in female germ cells
CN103146644B (zh) * 2013-02-27 2014-09-24 青岛农业大学 一种小鼠毛囊干细胞体外向原始生殖细胞分化的技术方法
CN103969232A (zh) * 2014-04-03 2014-08-06 浙江大学 一种三色荧光标记筛选抗阿霉素肾毒性活性物质的方法
KR20170056521A (ko) 2014-09-16 2017-05-23 오바사이언스, 인크. 항-vasa 항체, 및 이것의 제조 및 사용 방법
MX2017007463A (es) * 2014-12-08 2018-03-23 Ovascience Inc Recolección y concentración de mitocondrias y usos de las mismas.
WO2017065839A1 (en) * 2015-10-16 2017-04-20 Coopersurgical, Inc. Quantification of mitochondrial dna and methods for determining the quality of an embryo
WO2017197425A1 (en) * 2016-05-18 2017-11-23 Hudson Institute of Medical Research A method of treatment
US11103537B2 (en) 2016-06-23 2021-08-31 Tithon Biotech Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
AU2017281631B2 (en) * 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
CN106190963A (zh) * 2016-07-13 2016-12-07 浙江大学 一种采用线粒体移植促进损伤神经元存活的方法
WO2019060297A1 (en) * 2017-09-19 2019-03-28 Unity Biotechnology, Inc. MITOCHONDRIAL REJUVENATION AS A TREATMENT FOR AGE-RELATED AND NEURODEGENERATIVE CONDITIONS
CN108004200A (zh) * 2017-12-01 2018-05-08 佳学基因医学技术（北京）有限公司 一种线粒体转移液及其制备方法
CN111621555A (zh) * 2019-06-13 2020-09-04 中国科学院广州生物医药与健康研究院 生物标志物及其应用
EP4106649A4 (en) * 2020-02-20 2024-04-24 Northeastern University METHODS AND COMPOSITIONS FOR USING MITOCHONDRIAL THERAPIES TO IMPROVE FEMALE REPRODUCTIVE POTENTIAL
CN114134106B (zh) * 2021-11-26 2024-01-26 北京大学人民医院 一种尿源间充质干细胞线粒体及其移植方法与应用
CN116024296A (zh) * 2022-11-25 2023-04-28 中国科学院深圳先进技术研究院 一种基于有机荧光探针评估活生殖细胞及其早期胚胎线粒体状态的应用方法

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854470A (en) 1973-11-23 1974-12-17 L Augspurger Reproduction processes for cellular bodies
IT1057895B (it) 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
US4193392A (en) 1977-09-23 1980-03-18 Barnett Gordon R Method for removing ova from animals
US4326505A (en) 1980-01-07 1982-04-27 Occidental Petroleum Corporation Surgical procedure for embryo transplants on animals
US4339434A (en) 1981-08-17 1982-07-13 Gametrics Limited Method of increasing the incidence of female offspring
US4845077A (en) 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
FR2563726B1 (fr) 1984-05-04 1986-10-10 Robert Cassou Appareil d'insemination artificielle, notamment des carnivores
US4642094A (en) 1984-05-29 1987-02-10 North Jr Walter L Non-surgical embryo transfer device
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
FR2580933B1 (fr) 1985-04-24 1987-08-07 Lenck Lucien Capacite trans-uterine pour fecondation " in vitro in vivo "
FR2589879B1 (fr) 1985-11-08 1989-05-12 Claude Ranoux Conteneur pour culture anaerobie d'embryons humains
AT387718B (de) 1986-04-09 1989-03-10 Fischl Franz H Dr Katheder zur kuenstlichen befruchtung
FR2608037A1 (fr) 1986-12-10 1988-06-17 Lenck Lucien Methode d'intubation destinee a permettre la transplantation de l'oeuf ou de la matiere embryonnaire, et moyens pour sa mise en oeuvre
FR2609885B1 (fr) 1987-01-22 1989-04-14 Cassou Robert Instrument pour l'insemination artificielle, le transfert d'embryons ou le prelevement de liquides folliculaires chez les mammiferes
US5538948A (en) 1987-01-30 1996-07-23 Novo Nordisk A/S Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone
US4865589A (en) 1987-04-22 1989-09-12 Ludwig Simmet Instrument for the transfer of materials such as sperm and embryos
FR2614626B1 (fr) 1987-04-30 1989-07-21 Ranoux Claude Conteneur pour fecondation des ovocytes et replacement des embryons chez l'homme et l'animal
US5160312A (en) 1990-02-09 1992-11-03 W. R. Grace & Co.-Conn. Cryopreservation process for direct transfer of embryos
US5147315A (en) 1990-04-06 1992-09-15 C. R. Bard, Inc. Access catheter and system for use in the female reproductive system
EP0585349A4 (en) 1991-05-14 1994-12-07 Sinai School Medicine METHOD AND APPARATUS FOR IN-VITRO FERTILIZATION.
US5627066A (en) 1991-05-14 1997-05-06 Mount Sinai School Of Medicine Of The City University Of New York Method and apparatus for in vitro fertilization
FR2678506B1 (fr) 1991-07-01 2000-03-10 Claude Ranoux Procede de fecondation en cycle spontane.
US5744366A (en) 1992-05-01 1998-04-28 Trustees Of The University Of Pennsylvania Mesoscale devices and methods for analysis of motile cells
US5296375A (en) 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
GB9227123D0 (en) 1992-12-30 1993-02-24 Applied Research Systems Method
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
GB9305984D0 (en) 1993-03-23 1993-05-12 Royal Free Hosp School Med Predictive assay
US5360389A (en) 1993-05-25 1994-11-01 Chenette Philip E Methods for endometrial implantation of embryos
US5541081A (en) 1994-03-22 1996-07-30 President And Fellows Of Harvard College Process for assessing oocyte and embryo quality
GB9410639D0 (en) 1994-05-27 1994-07-13 Queen Mary & Westfield College Method of improving fertilization
JP3660026B2 (ja) 1995-09-04 2005-06-15 扶桑薬品工業株式会社 体外受精用培地組成物
US5827174A (en) 1995-09-26 1998-10-27 Reuss, Jr.; William Alexander Biological speciman containment and incubation pouch
US6040340A (en) 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
US5824548A (en) 1996-05-29 1998-10-20 Wisconsin Alumni Research Foundation Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
CA2199663C (en) 1997-03-11 2004-08-10 Ruth Miriam Moses In vitro maturation and fertilization of mammalian oocytes
US5935968A (en) 1997-03-17 1999-08-10 Merck & Co., Inc. Methods for treating polycystic ovary syndrome
US6010448A (en) 1997-10-17 2000-01-04 Medworks Corp Embryo transfer arrangement
US5961444A (en) 1997-10-17 1999-10-05 Medworks Corporation In vitro fertilization procedure using direct vision
US6196965B1 (en) 1998-05-21 2001-03-06 Cryofacets, Inc. Compositions methods and devices for embryo implantation for in vitro fertilization
BR0008468A (pt) 1999-02-24 2002-02-05 Novo Nordisk As Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos
DE60034662T2 (de) 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
EP1234021A2 (en) * 1999-10-27 2002-08-28 Mount Sinai Hospital Methods and compositions for enhancing developmental potential of oocytes and zygotes
WO2001036445A1 (en) 1999-11-18 2001-05-25 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
US6875854B1 (en) 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
NZ521711A (en) * 2000-04-14 2005-03-24 Advanced Cell Tech Inc Modified oocytes and embryonic non-human stem cells able to be cultured into a variety of differentiated cell types
FR2812004B1 (fr) 2000-07-24 2002-12-27 Ccd Lab Milieux de culture pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons
US20030134422A1 (en) * 2002-01-16 2003-07-17 Sayre Chauncey Bigelow Stem cell maturation for all tissue lines
WO2005007687A1 (en) 2003-07-09 2005-01-27 Dana-Farber Cancer Institute, Inc Compositions and methods for modulating ovarian follicular initiation
US20050130302A1 (en) 2003-09-29 2005-06-16 Reprocell Inc. Method and composition for regulating expansion of stem cells
EP1765983A4 (en) 2004-05-17 2008-10-22 Gen Hospital Corp METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STEM CELLS FROM GERMINAL STEM CELLS DERIVED FROM SPINAL CORD
US7955846B2 (en) * 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
US8232077B2 (en) * 2005-07-06 2012-07-31 Ovacyte Llc Oocytes derived from ovarian culture initially containing no oocytes
WO2008157398A1 (en) 2007-06-13 2008-12-24 Litron Laboratories Ltd. Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
US20090111764A1 (en) 2007-10-25 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Mitochondrial selection
WO2010124123A1 (en) * 2009-04-24 2010-10-28 Oregon Health & Science University Methods for mitochondrial dna replacement in oocytes
CN103562378B (zh) 2011-04-14 2016-09-07 通用医疗公司 用于自体种系线粒体能量转移的组合物和方法
EP3495470A1 (en) * 2011-06-29 2019-06-12 The General Hospital Corporation In vivo methods for enhancing bioenergetic status in female germ cells
JP5608834B1 (ja) * 2012-12-27 2014-10-15 パナソニック インテレクチュアル プロパティ コーポレーション オブ アメリカ 映像表示方法

Also Published As

Publication number Publication date
CA2868239A1 (en) 2012-10-18
EP2787073A1 (en) 2014-10-08
EP2697365A2 (en) 2014-02-19
AU2012242591B2 (en) 2014-10-23
CR20130592A (es) 2014-03-05
JP2014514928A (ja) 2014-06-26
US20130060079A1 (en) 2013-03-07
US20150353887A1 (en) 2015-12-10
PE20141517A1 (es) 2014-10-25
SG194448A1 (en) 2013-12-30
BR112013026501A2 (pt) 2016-11-29
NZ706806A (en) 2016-12-23
MX2013011990A (es) 2013-11-20
JP5793237B2 (ja) 2015-10-14
AU2012242591A1 (en) 2013-10-17
DOP2013000240A (es) 2014-06-30
CN103562378A (zh) 2014-02-05
EP2787073B1 (en) 2019-03-20
HK1202890A1 (en) 2015-10-09
US20130052727A1 (en) 2013-02-28
GT201300248A (es) 2015-09-01
ZA201308494B (en) 2016-02-24
US20190300850A1 (en) 2019-10-03
NI201300108A (es) 2014-08-26
IL228829A (en) 2015-02-26
CN103562378B (zh) 2016-09-07
US8647869B2 (en) 2014-02-11
EP3498826A1 (en) 2019-06-19
AP2013007229A0 (en) 2013-11-30
US8642329B2 (en) 2014-02-04
CA2832336C (en) 2016-08-09
JP2018007659A (ja) 2018-01-18
CA2832336A1 (en) 2012-10-18
CO6862102A2 (es) 2014-02-10
WO2012142500A3 (en) 2012-12-13
MA35105B1 (fr) 2014-05-02
SG10201406171QA (en) 2014-10-30
WO2012142500A2 (en) 2012-10-18
IL237089A (en) 2017-05-29
CA2868239C (en) 2018-07-31
EA201391523A1 (ru) 2014-03-31
EP2697365A4 (en) 2014-07-23
IL247447B (en) 2018-10-31
JP6170103B2 (ja) 2017-07-26
US9150830B2 (en) 2015-10-06
CN106350479A (zh) 2017-01-25
ZA201502630B (en) 2016-01-27
IL228829A0 (en) 2013-12-31
JP2016019532A (ja) 2016-02-04
US20120315651A1 (en) 2012-12-13
NZ617582A (en) 2015-06-26

Similar Documents

Publication Publication Date Title
CL2013002989A1 (es) Composicion para ser transferida a un ovocito que es preparado para fertilizacion in vitro o inseminacion artificial.
ES2541486T3 (es) Injertos quirúrgicos para reparar defectos condrales
BR112013004616A2 (pt) diferenciação das células tronco embrionárias humanas
BR112012015727A2 (pt) diferenciacao de celulas-tronco embrionarias humanas
AR082820A1 (es) Diferenciacion de celulas madre embrionarias humanas
JP2014514928A5 (es)
BR112015015770A2 (pt) cultivo de células-tronco embrionárias humanas na interface ar-líquido para diferenciação em células pancreáticas endócrinas
WO2015054526A3 (en) Methods of mammalian retinal stem cell production and applications
AR085507A1 (es) Animales modificados geneticamente y metodos para su obtencion
BR112016011998A2 (pt) Método para o enriquecimento em carotenoides e o enriquecimento em proteínas de uma biomassa de microalgas cultivada heterotroficamente
BR112017018885A2 (pt) método de cultura celular para células-tronco mesenquimais
AR078805A1 (es) Celulas madre pluripotentes
BR112014027783A2 (pt) diferenciação de células-tronco embrionárias humanas em endoderma pancreático
CU20120007A7 (es) Método para la inducción de diferenciación de células madre mesenquimales
CL2011002518A1 (es) Proceso para producir un vegetal, una semilla o su progenie, basado en transformar células vegetales con una secuencia de ácido nucleico que codifica una proteína quinasa relacionada con snf1, vector que comprende dicha secuencia; y métodos de aplicación.
BR112014020183A8 (pt) Método de manutenção e enriquecimento de células-tronco espermatogoniais (sscs), método enriquecimento de células-tronco espermatogoniais (sscs), meio para manutenção e enriquecimento de células-tronco espermatogoniais bovinas, população de células-tronco espermatogoniais enriquecidas, método para gerar pelo menos um descendente mamífero
WO2012071393A3 (en) Method for producing pluripotent stem cells
AR095348A1 (es) Medios de cultivo celular y métodos de producción de anticuerpos
MY172702A (en) Production of fertile xy female animals from xy es cells
AR072206A1 (es) Sistema en continuo de transformacion de co2 en productos de alto valor anadido y/o valor nutricional y otros recursos energeticos
PH12020550798A1 (en) Materials and methods including for sex selection
BR112016018826A8 (pt) anticorpo purificado, ou fragmento de ligação de antígeno, método para a identificação de uma população de células de esperma de mamífero portadoras de cromossomo x, e método in vitro para distorcer uma proporção entre os sexos
BR112017007213A2 (pt) "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero"
PE20170625A1 (es) Procedimiento para generacion de gemelos homocigoticos por biparticion embrionaria
TH139057A (th) องค์ประกอบและวิธีการสำหรับการส่งผ่านพลังงานของไมโตคอนเดรียในเซลล์ ต้นกำเนิดของตัวมันเอง (Autologous Germline Mitochondrial Energy transfer)